<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00125684</url>
  </required_header>
  <id_info>
    <org_study_id>10181</org_study_id>
    <nct_id>NCT00125684</nct_id>
  </id_info>
  <brief_title>Bioavailability and Effectiveness of Transdermally Administered Morphine</brief_title>
  <official_title>Bioavailability and Effectiveness of Transdermally Administered Morphine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alberta Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tom Baker Cancer Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AHS Cancer Control Alberta</source>
  <brief_summary>
    <textblock>
      Patients will participate in two arms of the trial, one in which morphine will be
      administered transdermally, and, after a 3 day wash out period, one in which morphine will be
      administered subcutaneously.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will participate in two arms of the trial, one in which morphine will be
      administered transdermally, and, after a 3 day wash out period, one in which morphine will be
      administered subcutaneously. Blood draws will be done after both dosing methods in order to
      compare blood levels of morphine by the different routes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2003</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>detectable morphine levels in serum</measure>
  </primary_outcome>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Cancer</condition>
  <condition>Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic cancer pain

          -  Minimum baseline pain of 3/10

          -  No change in medications over 3 days prior to study period

          -  Ability to give informed consent

          -  Willingness to undergo repeated blood sampling

        Exclusion Criteria:

          -  Use of morphine or codeine in 3 days prior to study

          -  Known sensitivity to morphine

          -  Prior anaphylactic reaction to any opioid

          -  Clinically significant anemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Hagen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alberta Cancerboard</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2005</study_first_submitted>
  <study_first_submitted_qc>August 1, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2005</study_first_posted>
  <last_update_submitted>January 18, 2012</last_update_submitted>
  <last_update_submitted_qc>January 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alberta Health Services</investigator_affiliation>
    <investigator_full_name>Rachel Syme</investigator_full_name>
    <investigator_title>Dr. Neil Hagen - Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>transdermal morphine</keyword>
  <keyword>cancer</keyword>
  <keyword>pain</keyword>
  <keyword>bioavailability</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>cancer related pain</keyword>
  <keyword>stable baseline pain</keyword>
  <keyword>currently taking opioids</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

